Task: Answer the multiple-choice question.
Question: Which compound exhibits a -2.536\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CCOC(=O)c1ccc(NC(=O)CN2C(=O)C(CC)SC(CC)C2=O)cc1
b) CCC(C)n1c(SCC(=O)Nc2ccccc2C(F)(F)F)nc2ccsc2c1=O
Answer: b. CCC(C)n1c(SCC(=O)Nc2ccccc2C(F)(F)F)nc2ccsc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)n1c(SCC(=O)Nc2ccccc2C(F)(F)F)nc2ccsc2c1=O
CCC(C)n1c(SCC(=O)Nc2ccccc2C(F)(F)F)nc2ccsc2c1=O
2-(3-butan-2-yl-4-oxothieno[3,2-d]pyrimidin-2-yl)sulfanyl-N-[2-(trifluoromethyl)phenyl]acetamide